GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Grand Brilliance Group Holdings Ltd (HKSE:08372) » Definitions » 5-Year RORE %

Grand Brilliance Group Holdings (HKSE:08372) 5-Year RORE % : 12.50% (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Grand Brilliance Group Holdings 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Grand Brilliance Group Holdings's 5-Year RORE % for the quarter that ended in Sep. 2023 was 12.50%.

The industry rank for Grand Brilliance Group Holdings's 5-Year RORE % or its related term are showing as below:

HKSE:08372's 5-Year RORE % is ranked better than
64.2% of 81 companies
in the Medical Distribution industry
Industry Median: 5.08 vs HKSE:08372: 12.50

Grand Brilliance Group Holdings 5-Year RORE % Historical Data

The historical data trend for Grand Brilliance Group Holdings's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Brilliance Group Holdings 5-Year RORE % Chart

Grand Brilliance Group Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
5-Year RORE %
Get a 7-Day Free Trial - - - 52.63 6.67

Grand Brilliance Group Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.22 4.35 6.67 16.00 12.50

Competitive Comparison of Grand Brilliance Group Holdings's 5-Year RORE %

For the Medical Distribution subindustry, Grand Brilliance Group Holdings's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grand Brilliance Group Holdings's 5-Year RORE % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Grand Brilliance Group Holdings's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Grand Brilliance Group Holdings's 5-Year RORE % falls into.



Grand Brilliance Group Holdings 5-Year RORE % Calculation

Grand Brilliance Group Holdings's 5-Year RORE % for the quarter that ended in Sep. 2023 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( 0.011-0.008 )/( 0.044-0.02 )
=0.003/0.024
=12.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2023 and 5-year before.


Grand Brilliance Group Holdings  (HKSE:08372) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Grand Brilliance Group Holdings 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Grand Brilliance Group Holdings's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Grand Brilliance Group Holdings (HKSE:08372) Business Description

Traded in Other Exchanges
N/A
Address
6 Sha Tsui Road, The Octagon, Units 2901-2903 and 2905, 29th Floor, New Territories, Tsuen Wan, Hong Kong, HKG
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. The company serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.
Executives
Miu Yin Shun Andrew 2202 Interest of your spouse
Wong Bik Kwan Bikie 2101 Beneficial owner
B&a Success Limited 2101 Beneficial owner

Grand Brilliance Group Holdings (HKSE:08372) Headlines

No Headlines